Investment led by BGF, with support from existing investors F-Prime Capital, Kindred Capital, and Jonathan Milner Seed funding will accelerate development of Shift Bioscience’s platform for ...
CAMBRIDGE, England--(BUSINESS WIRE)--Shift Bioscience is a biotech company using generative AI models to understand how activation of different genes can reverse the aging process. This research is a ...
Shift Bioscience is building a cell simulation platform that combines generative AI with its highly accurate, high-throughput biological aging clock, to predict which sets of genes are most likely to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback